Published in Oxid Med Cell Longev on June 09, 2016
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 64.62
Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell (1993) 33.79
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 32.26
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A (2006) 10.09
The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med (2007) 7.59
The microRNA spectrum in 12 body fluids. Clin Chem (2010) 6.82
Circulating microRNAs in patients with coronary artery disease. Circ Res (2010) 6.28
Oxidant signals and oxidative stress. Curr Opin Cell Biol (2003) 5.67
MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol (2011) 5.46
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J (2010) 5.04
MiR423-5p as a circulating biomarker for heart failure. Circ Res (2010) 3.83
MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proc Natl Acad Sci U S A (2005) 3.78
Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet (2010) 3.75
MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol (2009) 3.19
Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure. J Mol Cell Cardiol (2001) 3.01
Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes (2009) 2.78
Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation (2009) 2.70
Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation (2011) 2.60
Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res (2013) 2.52
Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation (2011) 2.52
Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study. Circulation (2015) 2.48
Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res (2000) 2.45
microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease. Blood (2010) 2.34
Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy. J Am Coll Cardiol (2013) 2.25
Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail (2011) 2.08
Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res (2011) 2.02
Assessment of plasma miRNAs in congestive heart failure. Circ J (2010) 2.00
MicroRNA-24 regulates vascularity after myocardial infarction. Circulation (2011) 1.98
Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol (2011) 1.94
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun (2012) 1.88
MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell (2011) 1.84
miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ (2011) 1.77
Transcoronary concentration gradients of circulating microRNAs. Circulation (2011) 1.76
Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol (2010) 1.66
microRNAs in cardiovascular diseases: current knowledge and the road ahead. J Am Coll Cardiol (2014) 1.61
Circulating microRNAs: novel biomarkers for cardiovascular diseases. J Mol Med (Berl) (2011) 1.54
MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J Clin Invest (2013) 1.49
miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival. Circ Res (2015) 1.41
MicroRNAs in cardiovascular disease: an introduction for clinicians. Heart (2015) 1.38
NADPH oxidases in heart failure: poachers or gamekeepers? Antioxid Redox Signal (2012) 1.27
MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure. Eur J Heart Fail (2015) 1.24
Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients. Eur J Heart Fail (2013) 1.20
MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genomics (2010) 1.17
miR-146a is modulated in human endothelial cell with aging. Atherosclerosis (2011) 1.14
Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers. Proc Natl Acad Sci U S A (2014) 1.14
MicroRNAs are involved in homocysteine-induced cardiac remodeling. Cell Biochem Biophys (2009) 1.11
Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders. Eur J Heart Fail (2013) 1.10
Oxidative stress and microRNAs in vascular diseases. Int J Mol Sci (2013) 1.10
Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure. Eur J Heart Fail (2013) 1.09
MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart. J Mol Cell Cardiol (2013) 1.09
Mir-24 regulates junctophilin-2 expression in cardiomyocytes. Circ Res (2012) 1.07
miR-499 protects cardiomyocytes from H 2O 2-induced apoptosis via its effects on Pdcd4 and Pacs2. RNA Biol (2014) 1.06
Heart failure care in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med (2014) 1.06
SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway. Eur Heart J (2012) 1.05
Ultrastructural uncoupling between T-tubules and sarcoplasmic reticulum in human heart failure. Cardiovasc Res (2013) 1.03
Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction. Dis Markers (2013) 0.99
Relations between circulating microRNAs and atrial fibrillation: data from the Framingham Offspring Study. Heart Rhythm (2014) 0.99
Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases. Heart Lung Circ (2014) 0.97
Circulating MicroRNAs in cardiovascular disease. Circulation (2011) 0.96
Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction). J Mol Cell Cardiol (2016) 0.95
Glucose depletion activates mmu-miR-466h-5p expression through oxidative stress and inhibition of histone deacetylation. Nucleic Acids Res (2012) 0.94
Serum miR-210 and miR-30a expressions tend to revert to fetal levels in Chinese adult patients with chronic heart failure. Cardiovasc Pathol (2013) 0.94
Circulating miRNA as novel markers for diastolic dysfunction. Mol Cell Biochem (2012) 0.94
A novel microRNA mmu-miR-466h affects apoptosis regulation in mammalian cells. Biotechnol Bioeng (2011) 0.93
Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device. Eur J Heart Fail (2014) 0.90
MicroRNA-214 Is Upregulated in Heart Failure Patients and Suppresses XBP1-Mediated Endothelial Cells Angiogenesis. J Cell Physiol (2015) 0.89
Decreased expression of miR-133a but not of miR-1 is associated with signs of heart failure in patients undergoing coronary bypass surgery. Cardiology (2013) 0.89
Unique anti-apoptotic activity of EAAC1 in injured motor neurons. EMBO J (2006) 0.89
MicroRNA profiling of pericardial fluid samples from patients with heart failure. PLoS One (2015) 0.88
Detection of microRNAs in dried serum blots. Anal Biochem (2010) 0.88
Angiotensin receptor type 1 single nucleotide polymorphism 1166A/C is associated with malignant arrhythmias and altered circulating miR-155 levels in patients with chronic heart failure. J Card Fail (2012) 0.87
Redox mechanisms of cardiomyocyte mitochondrial protection. Front Physiol (2015) 0.85
Characterization of circulating microRNA expression in patients with a ventricular septal defect. PLoS One (2014) 0.84
NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice. Eur Heart J (2015) 0.84
miR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo. PLoS One (2014) 0.84
The transcardiac gradient of cardio-microRNAs in the failing heart. Eur J Heart Fail (2016) 0.83
Circulating miR-21, miR-378, and miR-940 increase in response to an acute exhaustive exercise in chronic heart failure patients. Oncotarget (2016) 0.83
Circulating miR-765 and miR-149: potential noninvasive diagnostic biomarkers for geriatric coronary artery disease patients. Biomed Res Int (2015) 0.82
MiR-25 protects cardiomyocytes against oxidative damage by targeting the mitochondrial calcium uniporter. Int J Mol Sci (2015) 0.82
By targeting Stat3 microRNA-17-5p promotes cardiomyocyte apoptosis in response to ischemia followed by reperfusion. Cell Physiol Biochem (2014) 0.81
Inhibition of miR-200c Restores Endothelial Function in Diabetic Mice Through Suppression of COX-2. Diabetes (2016) 0.81
Differential regulation of microRNAs in end-stage failing hearts is associated with left ventricular assist device unloading. Biomed Res Int (2015) 0.81
Post-transcriptional regulation of α-1-antichymotrypsin by microRNA-137 in chronic heart failure and mechanical support. Circ Heart Fail (2013) 0.80
MicroRNA-1 aggravates cardiac oxidative stress by post-transcriptional modification of the antioxidant network. Cell Stress Chaperones (2015) 0.80
Circulating microribonucleic acids miR-1, miR-21 and miR-208a in patients with symptomatic heart failure: Preliminary results. Arch Cardiovasc Dis (2015) 0.80
Identification of cardiac-related circulating microRNA profile in human chronic heart failure. Oncotarget (2015) 0.80
The diagnostic value of circulating microRNAs for middle-aged (40-60-year-old) coronary artery disease patients. Clinics (Sao Paulo) (2015) 0.80
MicroRNAs relate to early worsening of renal function in patients with acute heart failure. Int J Cardiol (2015) 0.79
The SUR2B subunit of rat vascular KATP channel is targeted by miR-9a-3p induced by prolonged exposure to methylglyoxal. Am J Physiol Cell Physiol (2014) 0.79
Trimetazidine improves right ventricular function by increasing miR-21 expression. Int J Mol Med (2012) 0.79
Beneficial Effects of Physical Exercise on Functional Capacity and Skeletal Muscle Oxidative Stress in Rats with Aortic Stenosis-Induced Heart Failure. Oxid Med Cell Longev (2016) 0.79
SOX6 and PDCD4 enhance cardiomyocyte apoptosis through LPS-induced miR-499 inhibition. Apoptosis (2016) 0.79
microRNA-340-5p Functions Downstream of Cardiotrophin-1 to Regulate Cardiac Eccentric Hypertrophy and Heart Failure via Target Gene Dystrophin. Int Heart J (2015) 0.78
Micro-RNA and mRNA myocardial tissue expression in biopsy specimen from patients with heart failure. Int J Cardiol (2015) 0.78
Relationship between local production of microRNA-328 and atrial substrate remodeling in atrial fibrillation. J Cardiol (2016) 0.78
Cardiac-targeted NADPH oxidase 4 in the adaptive cardiac remodelling of the murine heart. Lancet (2015) 0.76
Regulation of cellular oxidative stress and apoptosis by G protein-coupled receptor kinase-2; The role of NADPH oxidase 4. Cell Signal (2015) 0.76
ATP sensitive K(+) channels are critical for maintaining myocardial perfusion and high energy phosphates in the failing heart. J Mol Cell Cardiol (2016) 0.76
MiR-17-5p impairs trafficking of H-ERG K+ channel protein by targeting multiple er stress-related chaperones during chronic oxidative stress. PLoS One (2013) 0.76